Predictive factors of recurrence for patients with intrahepatic cholangiocarcinoma after hepatectomy

Hepato-Gastroenterology

Volumn 59, Issue 118, 2012, Pages 1765-1768

  Chen, Li Ping ^a   Li, Chuan ^a   Wang, Chuan ^a   Wen, Tian Fu ^a   Yan, Lu Nan ^a   Li, Bo ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Intrahepatic cholangiocarcinoma; Negative resection margin; Risk factor

Indexed keywords

ADULT; ARTICLE; BILE DUCT CARCINOMA; CANCER INVASION; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; DIAGNOSTIC ACCURACY; FEMALE; HISTOPATHOLOGY; HUMAN; LIVER METASTASIS; LIVER RESECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PREDICTOR VARIABLE; PRIORITY JOURNAL; RECURRENCE FREE SURVIVAL; RISK ASSESSMENT; SURVIVAL RATE; TUMOR LOCALIZATION; TUMOR VOLUME;

ADULT; AGED; CHI-SQUARE DISTRIBUTION; CHINA; CHOLANGIOCARCINOMA; DISEASE-FREE SURVIVAL; FEMALE; HEPATECTOMY; HUMANS; KAPLAN-MEIER ESTIMATE; LIVER NEOPLASMS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM INVASIVENESS; NEOPLASM RECURRENCE, LOCAL; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT; RISK FACTORS; ROC CURVE; TIME FACTORS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 84867702178     PISSN: 01726390     EISSN: None     Source Type: Journal    
DOI: 10.5754/hge11820     Document Type: Article

References (28)

1. Cho SY, Park SJ, Kim SH, et al.: Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol 2010; 17:1823-1830.
2. Nuzzo G, Giuliante F, Ardito F, et al.: Intrahepatic cholangiocarcinoma: prognostic factors after liver resection. Updates Surg 2010; 62:11-19.
3. Patel T: Worldwide trends in mortality from biliary tract malignancies. BMC Cancer 2002; 2:10.
4. Tao LY, He XD, Qu Q, et al.: Risk factors for intrahepatic and extrahepatic cholangiocarcinoma: a case-control study in China. Liver Int 2010; 30:215-221.
5. Zhou YM, Yin ZF, Yang JM, et al.: Risk factors for intrahepatic cholangiocarcinoma: a case-control study in China. World J Gastroenterol 2008; 14:632-635.
6. Zhang L, Cai JQ, Zhao JJ, et al.: Impact of hepatitis B virus infection on outcome following resection for intrahepatic cholangiocarcinoma. J Surg Oncol 2011; 101:233-238.
7. Pinson CW, Moore DE: Liver transplantation is not indicated for cholangiocarcinoma. HPB (Oxford) 2003; 5:203-205. (Pubitemid 38008073)
8. Yamamoto M, Ariizumi S: Intrahepatic recurrence after surgery in patients with intrahepatic cholangiocarcinoma. J Gastroenterol 2006; 41:925-926. (Pubitemid 44594238)
9. Poggi G, Quaretti P, Minoia C, et al.: Oxaliplatin-eluting microspheres for the treatment of intrahepatic cholangiocarcinoma: a case report. Anticancer Res 2008; 28:2987-2990.
10. Murakami Y, Uemura K, Sudo T, et al.: Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol 2010; 18:651-658.
11. Shimada K, Sano T, Sakamoto Y, et al.: Surgical outcomes of the mass-forming plus periductal infiltrating types of intrahepatic cholangiocarcinoma: a comparative study with the typical mass-forming type of intrahepatic cholangiocarcinoma. World J Surg 2007; 31:2016-2022. (Pubitemid 47415732)
12. Uenishi T, Kubo S, Yamazaki O, et al.: Indications for surgical treatment of intrahepatic cholangiocarcinoma with lymph node metastases. J Hepatobiliary Pancreat Surg 2008; 15:417-422.
13. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N: Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg 2008; 32:2675-2680.
14. Hammill CW, Wong LL: Intrahepatic cholangiocarcinoma: a malignancy of increasing importance. J Am CoIl Surg 2008; 207:594-603.
15. Shimada K, Sano T, Sakamoto Y, et al.: Clinical impact of the surgical margin status in hepatectomy for solitary mass-forming type intrahepatic cholangiocarcinoma without lymph node metastases. J Surg Oncol 2007; 96:160-165. (Pubitemid 47264820)
16. Fan ST, Mau Lo C, Poon RT, et al.: Continuous improvement of survival outcomes of resection of hepatocellular carcinoma: a 20-year experience. Ann Surg 2011; 253:745-758.
17. Saiura A, Yamamoto J, Kokudo N, et al.: Intrahepatic cholangiocarcinoma: analysis of 44 consecutive resected cases including 5 cases with repeat resections. Am J Surg 2011; 201:203-208.
18. Hur H, Park IY, Sung GY, et al.: Intrahepatic cholangiocarcinoma associated with intrahepatic duct stones. Asian J Surg 2009; 32:7-12.
19. Jiang W, Zeng ZC, Tang ZY, et al.: Benefit of radiotherapy for 90 patients with resected intrahepatic cholangiocarcinoma and concurrent lymph node metastases. J Cancer Res Clin Oncol 2010; 136:1323-1331.
20. De Jong MC, Nathan H, Sotiropoulos GC, et al.: Intrahepatic cholangiocarcinoma: an international multi-institutional analysis of prognostic factors and lymph node assessment. J Clin Oncol 2011; 29:3140-3145.
21. Choi SB, Kim KS, Choi JY, et al.: The prognosis and survival outcome of intrahepatic cholangiocarcinoma following surgical resection: association of lymph node metastasis and lymph node dissection with survival. Ann Surg Oncol 2009; 16:3048-3056.
22. Kawarada Y, Yamagiwa K, Das BC: Analysis of the relationships between clinicopathologic factors and survival time in intrahepatic cholangiocarcinoma. Am J Surg 2002; 183:679-685. (Pubitemid 34722537)
23. Nakagawa T, Kamiyama T, Kurauchi N, et al.: Number of lymph node metastases is a significant prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2005; 29:728-733. (Pubitemid 41187533)
24. Tamandl D, Kaczirek K, Gruenberger B, et al.: Lymph node ratio after curative surgery for intrahepatic cholangiocarcinoma. Br J Surg 2009; 96:919-925.
25. Shirai K, Ebata T, Oda K, et al.: Perineural invasion is a prognostic factor in intrahepatic cholangiocarcinoma. World J Surg 2008; 32:2395-2402.
26. Sasaki A, Kawano K, Aramaki M, et al.: Correlation between tumor size and mode of spread in mass-forming intrahepatic cholangiocarcinoma. Hepato-gastroenterol 2004; 51:224-228. (Pubitemid 38283098)
27. Farges O, Fuks D, Le Treut YP, et al.: AJCC 7th edition of TNM staging accurately discriminates outcomes of patients with resectable intrahepatic cholangiocarcinoma: By the AFC-IHCC-2009 study group. Cancer 2011; 117:2170-2177.
28. Ribero D, Nuzzo G, Amisano M, et al.: Comparison of the prognostic accuracy of the sixth and seventh editions of the TNM classification for intrahepatic cholangiocarcinoma. HPB (Oxford) 2011; 13:198-205.